$AMCI Cashflow Statement | Understand Stock

$AMCI

$1.91 -$0.04 (2.05%) Close

$AMCI Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022
CASH FLOWS FROM OPERATING ACTIVITIES
Net income (loss)
Adjustments to reconcile net income (loss) to net cash provided by/(used in) operating activities:
Trust investment income
Unrealized loss on investments held in trust account
(Reversal) for credit losses - related party
Loss from the change of the FV of Warrant Liability-
Provision (reversal) for warranty
Inventory impairment provision
Non-cash lease expenses
Changes in operating assets and liabilities:
Accounts receivable
Accounts receivable - related party
Inventories, net
Prepaid expenses
Accounts payable and accrued offering costs and expenses
Due to related party
Trust investment income
Other payable
Promissory note – related party
Promissory note – third party
Other receivable
Other receivable - related party, net
Advance to suppliers
Advance to suppliers – related party
Other non-current assets
Due from stockholder
Prepayment - related party
Accounts payable
Accounts payable - related party
Accrued and other liabilities
Tax payable
Other payable - related party
Warranty liabilities - current portion
Warranty liabilities - noncurrent
Lease liability

Net cash provided by / (used in) operating activities
CASH FLOWS FROM INVESTING ACTIVITIES
Cash deposited to trust account
Cash deposited to trust escrow account
Issuance of note receivable – stockholder
Repayment of note receivable - stockholder
Repayment of promissory note
Net cash provided by (used in) investing activities
CASH FLOWS FROM FINANCING ACTIVITIES
Deferred offering cost
Capital contribution
Capital contribution from SPAC
Payments related to FPA arrangement
Proceeds from FPA settlement
Proceeds from PIPE shares issued
Gross Proceeds
Proceeds from private placement
Proceeds from over-allotment and private placement, net of underwriters’ discount
Proceeds from short term loan
Proceeds from note payable - related party
Proceeds from promissory note – third party
Redemption of ordinary shares
Repayment of note payable - related party
Net cash provided by (used in) financing activities

Effect of changes of foreign exchange rate on cash and cash equivalent
Net increase in cash and cash equivalents
Cash and cash equivalents - beginning of the period
Cash and cash equivalents - end of the period
Accretion for ordinary shares subject to redemption amount
Deferred offering costs paid by Sponsor in exchange for issuance of ordinary shares
Deferred offering costs included in due to accrued expenses
Accrued expenses converted to promissory note– related party
Accrued expenses converted to promissory note – third party
Prepaid expenses paid by promissory note – third party
Supplemental Cash Flow Disclosures
Cash paid for interest expenses
Cash paid for income taxes
NON-CASH INVESTING AND FINANCING ACTIVITIES
Non-cash activity from deconsolidation of VIEs
Non-cash reclassification of SPAC accumulated deficit to APIC
Right-of-use asset obtained in exchange for lease obligation
Unpaid deferred offering cost

Comments